Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12443044rdf:typepubmed:Citationlld:pubmed
pubmed-article:12443044lifeskim:mentionsumls-concept:C0015684lld:lifeskim
pubmed-article:12443044lifeskim:mentionsumls-concept:C0020197lld:lifeskim
pubmed-article:12443044lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:12443044lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:12443044lifeskim:mentionsumls-concept:C0700194lld:lifeskim
pubmed-article:12443044pubmed:dateCreated2002-11-21lld:pubmed
pubmed-article:12443044pubmed:abstractTextThe inhibitory effects of various fatty acids on three hyaluronidases (h-ST, h-SH and h-SD) and four chondroitinases (c-ABC, c-B, c-ACI and c-ACII) were examined, and their structure-activity relationships and mechanism of action were studied. The fatty acids used in this experiment showed various inhibitory activities against the enzymes. None of the fatty acids did not inhibit h-ST and h-SH. The saturated fatty acids (C10:0 to C22:0) showed very weak or no inhibition against h-SD, c-ABC, c-B, c-ACI and c-ACII but the unsaturated fatty acids (C14:1 to C24:1) with one double bond strongly inhibited the enzymes, and the inhibitory potency increased with increase in carbon chain length of the fatty acids. In contrast, the increase in number of double bonds caused a decrease in inhibitory potency against the enzymes. The position of the double bond and the stereochemistry of the cis-trans form of oleic acid (C18:1) did not influence the inhibitory potency against the enzymes. Carboxyl and hydroxyl groups in the fatty acid molecule were concerned in the inhibition of c-ACI. Among the fatty acids, eicosatrienoic acid (C20:3) generally inhibited h-SD, c-ABC, c-B and c-ACI, and nervonic acid (C24:1) was a potent inhibitor of c-ACII, and the fatty acids inhibited the enzymes in a noncompetitive manner.lld:pubmed
pubmed-article:12443044pubmed:languageenglld:pubmed
pubmed-article:12443044pubmed:citationSubsetIMlld:pubmed
pubmed-article:12443044pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12443044pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12443044pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12443044pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12443044pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12443044pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12443044pubmed:statusMEDLINElld:pubmed
pubmed-article:12443044pubmed:authorpubmed-author:UyedaMasaruMlld:pubmed
pubmed-article:12443044pubmed:authorpubmed-author:SuzukiKeitaro...lld:pubmed
pubmed-article:12443044pubmed:authorpubmed-author:TerasakiYoshi...lld:pubmed
pubmed-article:12443044pubmed:ownerNLMlld:pubmed
pubmed-article:12443044pubmed:authorsCompleteYlld:pubmed
pubmed-article:12443044pubmed:pagination183-6lld:pubmed
pubmed-article:12443044pubmed:dateRevised2007-3-21lld:pubmed
pubmed-article:12443044pubmed:articleTitleInhibition of hyaluronidases and chondroitinases by fatty acids.lld:pubmed
pubmed-article:12443044pubmed:affiliationLaboratory of Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, Kumamoto University, Japan.lld:pubmed